Evaluation of the Efficacy and Safety of the Sullivan Cochlear Implant.
Launched by TODOC · Jun 4, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effectiveness and safety of a new device called the Sullivan Cochlear Implant for people with hearing loss. It is designed for individuals aged 19 and older who have a specific type of hearing loss called sensorineural hearing loss, which means there's a problem with the inner ear or hearing nerve. To be eligible, participants should not have had a cochlear implant in the ear that will be treated, and they should not have certain medical conditions that could complicate surgery, like cancer or autoimmune diseases.
The trial will take place at one location and includes a group of participants who will receive the cochlear implant. They will be monitored over time to see how well the device works and whether it is safe to use. Before joining, participants will need to agree to be part of the study and sign a consent form. It's important to note that the trial is not yet recruiting participants, so interested individuals will need to wait until it officially begins.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with sensorineural hearing loss of 1 side or both sides (70 dBHL) or higher, aged 19 years or older
- • No previous cochlear implantation history in the ear scheduled for surgery
- • No contraindications to surgery, such as cochlear agenesis or auditory nerve agenesis, as determined by imaging tests
- • Patients without cancer, autoimmune disease, or neurological disease
- • Patients with a general condition that allows general anesthesia
- • Patients with no abnormalities in personality, depression, anxiety, sociality, or problem drinking tests
- • Use Korean
- • Patients who agree to participate in the clinical trial and sign a written consent form However, if the patient is unable to sign, the patient (if able to sign) and guardian (or agent) voluntarily agree to participate in the clinical trial and sign an informed consent form
- Exclusion Criteria:
- • Cases where electrode insertion is difficult due to severe internal malformation, cochlear ossification, etc.
- • Cases with cancer or autoimmune disease
- • Cases with a general condition that makes it difficult to tolerate general anesthesia
- • Cases with moderate or higher mental disability or where auditory training is difficult due to the absence of parents or supporters to assist with rehabilitation education
- • Cases deemed inappropriate for this test by the clinical trial manager
About Todoc
Todoc is a pioneering clinical trial sponsor dedicated to advancing innovative healthcare solutions through rigorous research and development. With a focus on precision medicine and patient-centric approaches, Todoc collaborates with leading institutions and regulatory bodies to ensure the highest standards of safety and efficacy in its clinical trials. Committed to transparency and ethical practices, the company leverages cutting-edge technology and data analytics to streamline trial processes, enhance patient engagement, and accelerate the delivery of transformative therapies to market. Through its unwavering dedication to scientific excellence, Todoc aims to significantly improve patient outcomes and contribute to the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported